Latest Breaking News On - Nobelpharma connect patient program - Page 1 : comparemela.com

Nobelpharma America Debuts New Product, HYFTOR™ (sirolimus topical gel) 0.2%, at the 2022 World TSC Conference

/PRNewswire/ Nobelpharma America, LLC, a pharmaceutical and medical device company headquartered in Bethesda, Maryland, will debut HYFTOR™ (sirolimus.